First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis

201413 citationsJournal Article

Authors

Good health and well-being

Published in: Multiple Sclerosis and Related Disorders

Volume 3, Issue 5, pp. 620-628

Field-Weighted Citation Impact: 1.28